Literature DB >> 19092579

Methicillin-resistant Staphylococcus aureus: a new pandemic?

Suzanne M Cuddy1.   

Abstract

The death rate in the United States is higher for methicillin-resistant Staphylococcus aureus (MRSA) than the death rate for AIDS. It has also been present for much longer than people realize. It is affecting all groups of individuals, children, and adults alike. Moreover, like AIDS, education is the key in preventing the spread of this disease. Because skin-to-skin contact is the main cause of MRSA transmission, simple good hand washing techniques remain crucial. New classes of antibiotics have been approved by the Food and Drug Administration for MRSA, as the challenge becomes continued antibiotic resistance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19092579     DOI: 10.1097/PSN.0b013e31818ea7ca

Source DB:  PubMed          Journal:  Plast Surg Nurs        ISSN: 0741-5206


  4 in total

1.  Inhibition of bacterial and fungal pathogens by the orphaned drug auranofin.

Authors:  Beth Burgwyn Fuchs; Rajmohan RajaMuthiah; Ana Carolina Remondi Souza; Soraya Eatemadpour; Rodnei Dennis Rossoni; Daniel Assis Santos; Juliana C Junqueira; Louis B Rice; Eleftherios Mylonakis
Journal:  Future Med Chem       Date:  2016-01-25       Impact factor: 3.808

Review 2.  Biologically active marine natural products and their molecular targets discovered using a chemical genetics approach.

Authors:  David E Williams; Raymond J Andersen
Journal:  Nat Prod Rep       Date:  2019-11-21       Impact factor: 13.423

3.  Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus.

Authors:  Rajmohan Rajamuthiah; Beth Burgwyn Fuchs; Annie L Conery; Wooseong Kim; Elamparithi Jayamani; Bumsup Kwon; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

4.  Whole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureus.

Authors:  Rajmohan Rajamuthiah; Beth Burgwyn Fuchs; Elamparithi Jayamani; Younghoon Kim; Jonah Larkins-Ford; Annie Conery; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.